Beijing Tiantan Biological Products Temettü
Temettü kriter kontrolleri 2/6
Beijing Tiantan Biological Products is a dividend paying company with a current yield of 0.58% that is well covered by earnings.
Anahtar bilgiler
0.6%
Temettü verimi
n/a
Geri Alım Getirisi
| Toplam Hissedar Getirisi | n/a |
| Gelecekteki Temettü Verimi | 1.0% |
| Temettü Büyümesi | -5.1% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | CN¥0.125 |
| Ödeme oranı | 20% |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Beijing Tiantan Biological Products Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Oct 29
Beijing Tiantan Biological Products (SHSE:600161) Ticks All The Boxes When It Comes To Earnings Growth
Oct 27Calculating The Fair Value Of Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161)
Oct 08Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Shares May Have Run Too Fast Too Soon
Sep 19Does Beijing Tiantan Biological Products (SHSE:600161) Deserve A Spot On Your Watchlist?
Jul 23Is Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 09Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Price Is Out Of Tune With Earnings
May 22We Think Beijing Tiantan Biological Products (SHSE:600161) Can Stay On Top Of Its Debt
Mar 16Do Beijing Tiantan Biological Products' (SHSE:600161) Earnings Warrant Your Attention?
Mar 01Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: 600161 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Büyüyen Temettü: 600161's dividend payments have increased, but the company has only paid a dividend for 7 years.
Piyasaya Karşı Temettü Getirisi
| Beijing Tiantan Biological Products Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (600161) | 0.6% |
| Pazarın Alt %25'i (CN) | 0.6% |
| Pazarın En İyi %25'i (CN) | 2.2% |
| Sektör Ortalaması (Biotechs) | 1.2% |
| Analist tahmini (600161) (3 yıla kadar) | 1.0% |
Önemli Temettü: 600161's dividend (0.58%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Yüksek Temettü: 600161's dividend (0.58%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its low payout ratio (19.6%), 600161's dividend payments are well covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its high cash payout ratio (91.6%), 600161's dividend payments are not well covered by cash flows.